These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 8486779)

  • 21. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women.
    Campos H; Walsh BW; Judge H; Sacks FM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3955-63. PubMed ID: 9398695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
    Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the Medications Working Group of the Lipid Research Clinics Program.
    Wallace RB; Hoover J; Barrett-Connor E; Rifkind BM; Hunninghake DB; Mackenthun A; Heiss G
    Lancet; 1979 Jul; 2(8134):112-5. PubMed ID: 88553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content.
    Khoo C; Campos H; Judge H; Sacks FM
    J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
    Castelli WP
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo studies of VLDL metabolism and LDL heterogeneity.
    Demant T; Packard C
    Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR; Havel RJ; Kane JP
    Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and metabolic considerations of long-term oral contraceptive use.
    Godsland IF; Crook D; Wynn V
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1955-63. PubMed ID: 1605285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels.
    Harris SS; Dawson-Hughes B
    J Am Coll Nutr; 1998 Jun; 17(3):282-4. PubMed ID: 9627916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
    Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
    Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
    Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.